AI assistant
Armata Pharmaceuticals, Inc. — Director's Dealing 2015
Aug 6, 2015
34152_dirs_2015-08-06_e7b69d13-98c6-4dd7-85ad-13e3a354a2e3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AmpliPhi Biosciences Corp (APHB)
CIK: 0000921114
Period of Report: 2015-08-05
Reporting Person: Salka Michael Scott (Director, Chief Executive Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-08-05 | Stock Option (right to buy) | $0.189 | A | 19985810 | Acquired | 2025-08-05 | Common Stock (19985810) | Direct |
Footnotes
F1: Two-thirds of the shares underlying this option will vest and become exercisable upon AmpliPhi Bioscience Corporation's (the "Company") satisfaction of certain business goals. One-third of the shares underlying this option will vest and become exercisable in accordance with the following schedule: 25% of such shares shall vest on the one year anniversary of the start of Mr. Salka's employment with the Company, and thereafter 1/48th of such shares shall vest on each monthly anniversary of the start of Mr. Salka's employment with the Company.